Loading live market data…

UroGen Pharma Ltd.

NASDAQ:URGN

$40.295 USD

$1.1 (2.82%)

Volume
452.78K
Average Volume
814.44K
Market Capitalization
$1.96B
P/E Ratio
-14.65
Dividend Yield
0.00%
Price Target
$42.50
Year High
$40.88
Year Low
$14.00
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$4.69

URGN Estimated and Actual Revenue by Quarter

URGN Estimated and Actual EPS by Quarter

URGN Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-12-31 1 -170.13M -131.76M -146.94M -170.87M -132.34M -147.58M
2028-09-30 1 -163.59M -126.7M -141.29M -164.3M -127.25M -141.9M
2028-06-30 1 -163.59M -126.7M -141.29M -164.3M -127.25M -141.9M
2028-03-31 1 -157.04M -121.63M -135.63M -157.73M -122.16M -136.23M
2027-12-31 2 -129.83M -100.55M -112.13M -130.39M -100.99M -112.62M
2027-09-30 2 -119.59M -92.62M -103.28M -120.11M -93.02M -103.73M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-12-31 1 35.23M 49.04M 40.69M 106.63M 137.68M 118.91M
2028-09-30 1 35.07M 48.82M 40.51M 102.53M 132.38M 114.34M
2028-06-30 1 36.33M 50.57M 41.96M 102.53M 132.38M 114.34M
2028-03-31 1 34.05M 47.4M 39.33M 98.43M 127.09M 109.76M
2027-12-31 2 20.88M 29.07M 24.12M 81.37M 105.07M 90.74M
2027-09-30 2 14.86M 20.69M 17.17M 74.95M 96.78M 83.58M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-12-31 1 139.3M 179.85M 155.34M 3 0.70204 0.97728 0.8109
2028-09-30 1 133.94M 172.94M 149.36M 3 0.69893 0.97294 0.8073
2028-06-30 1 133.94M 172.94M 149.36M 3 0.72395 1.00777 0.8362
2028-03-31 1 128.58M 166.02M 143.39M 3 0.67858 0.94462 0.7838
2027-12-31 2 106.3M 137.25M 118.54M 2 0.41613 0.57928 0.48066
2027-09-30 2 97.91M 126.42M 109.19M 2 0.29618 0.41229 0.3421